Apristar 125mg/80mg Capsule
By Apristar
Rx
3 Capsule in a Strip

Composition
Aprepitant(125mg) + Aprepitant(80mg)

Manufacturer - Lupin Ltd
Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India

Expires on or after
July, 2025

liver
Apristar 125mg/80mg Capsule appears to be safe for individuals with liver disease. The available data indicates that patients with liver issues may not require a dosage adjustment when using Apristar 125mg/80mg Capsule. It is advised to consult your physician regarding the use of this medication to ensure proper guidance.

kidney
Apristar 125mg/80mg Capsule is considered safe for use in patients with kidney disease, and no dose adjustment is necessary.

alcohol
Safety Advice - Alcohol Consult your doctor when consuming alcohol with Apristar 125mg/80mg Capsule.

driving
Apristar 125mg/80mg Capsule can reduce alertness and cause drowsiness or dizziness. Avoid driving if these effects happen to ensure safety on the road.

pregnancy
Information on the safety of Apristar 125mg/80mg Capsule during pregnancy is not available. It is advisable to consult your doctor before using this medication.

breastfeeding
Apristar 125mg/80mg Capsule may not be safe during breastfeeding. Limited data suggests potential harm to the baby through breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹2054.7
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024